Scott Morgan

Scott Morgan

MD, MSc, FRCPC

Clinician Investigator, Cancer Research

Ottawa Hospital Research Institute

Associate Professor, Radiation Oncology

University of Ottawa

Bio

Dr. Morgan is a radiation oncologist at The Ottawa Hospital Cancer Centre and an Associate Professor in the Division of Radiation Oncology at the University of Ottawa. He holds a Bachelor of Applied Science in Engineering Physics from the University of British Columbia, a Doctor of Medicine from Queen’s University, and a Master of Science in Clinical Trials from the University of London. Prior to starting his practice in Ottawa in 2010, he completed a fellowship in genitourinary clinical oncology at The Royal Marsden Hospital in London. His practice is focused on genitourinary and breast malignancy.

He is a longstanding member of the Genitourinary Disease Site Group of the Cancer Care Ontario Programme in Evidence-Based Care. Between 2016 and 2020, he served as Co-Chair of the Genitourinary Guideline Advisory Group of the American Society of Clinical Oncology. In 2020, he was appointed to the Guidelines Subcommittee of the American Society for Radiation Oncology.

Dr. Morgan serves on the Genitourinary Cancer Committee of NRG Oncology and the Genitourinary Executive Committee of the Canadian Cancer Trials Group. He is a member of the steering committees of four large-scale multicentre phase III trials in localized and advanced prostate cancer. He serves as Co-Chair of the Genitourinary Radiation Oncologists of Canada.


Research Goals and Interests

Dr. Morgan has a research interest in therapies for prostate cancer across its spectrum from localized to advanced disease. He has specific interests in evidence synthesis and evidence-based practice, large observational studies, and multicentre clinical trials.

Dr. Morgan has a research interest in therapies for prostate cancer across its spectrum from localized to advanced disease. He has specific interests in evidence synthesis and evidence-based practice, large observational studies, and multicentre clinical trials.


Publications

Canadian Prostate Cancer Trends in the Context of PSA Screening Guideline Changes

2025-11-01 Go to publication

Association of Short-Term Patient-Reported Outcomes With Long-Term Oncologic Outcomes in Localized Prostate Cancer Patients Treated With Radiation Therapy and Androgen Deprivation Therapy in a Randomized Controlled Trial

2022-01-01

Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada

2022-01-01

Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancer

2022-01-01

Association of Baseline Patient-reported Health-related Quality of Life Metrics with Outcome in Localised Prostate Cancer

2022-01-01

Related Research at The Ottawa Hospital